These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 79409)
1. Interferon inhibits C-type virus at a posttranscriptional, prerelease step. Billiau A; Heremans H; Allens PT; Baron S; de Somer P Arch Virol; 1978; 57(3):205-20. PubMed ID: 79409 [TBL] [Abstract][Full Text] [Related]
2. Effect of interferon on murine leukaemia virus infection. IV. Formation of non-infectious virus in chronically infected cells. Pitha PM; Wivel NA; Fernie BF; Harper HP J Gen Virol; 1979 Mar; 42(3):467-80. PubMed ID: 85689 [TBL] [Abstract][Full Text] [Related]
3. Deficiency of 60 to 70S RNA in murine leukemia virus particles assembled in cells treated with actinomycin D. Levin JG; Grimley PM; Ramseur JM; Berezesky IK J Virol; 1974 Jul; 14(1):152-61. PubMed ID: 4134468 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of murine leukemia virus proteins associated with virions assembled in actinomycin D-treated cells: evidence for persistence of viral messenger RNA. Levin JG; Rosenak MJ Proc Natl Acad Sci U S A; 1976 Apr; 73(4):1154-8. PubMed ID: 57617 [TBL] [Abstract][Full Text] [Related]
5. Differential sensitivity of Rauscher murine leukaemia virus (MuLV-R) to interferons in two interferon-responsive cell lines. Allen PT; Schellekens H; Van Griensven LJ; Billiau A J Gen Virol; 1976 Jun; 31(3):429-35. PubMed ID: 58965 [TBL] [Abstract][Full Text] [Related]
6. Effect of interferon on mouse leukaemia virus (MuLV). V. Abnormal proteins in virions of Rauscher MuLV produced in the presence of interferon. Pitha PM; Fernie B; Maldarelli F; Hattman T; Wivel NA J Gen Virol; 1980 Jan; 46(1):97-110. PubMed ID: 7351537 [TBL] [Abstract][Full Text] [Related]
7. The errors in assembly of MuLV in interferon treated cells. Pitha PM; Fernie B; Maldarelli F; Wivel NA J Supramol Struct; 1979; 12(1):35-46. PubMed ID: 94615 [TBL] [Abstract][Full Text] [Related]
8. Differential antiviral effects of interferon in three murine cell lines. Sen GC; Herz RE J Virol; 1983 Mar; 45(3):1017-27. PubMed ID: 6187940 [TBL] [Abstract][Full Text] [Related]
9. Effect of interferon on assembly of intracellular Moloney murine leukemia virus particles in chronically infected 3T3/NIH cells. Aboud M; Hassan Y; Huleihel M Arch Virol; 1982; 74(4):249-58. PubMed ID: 6187315 [TBL] [Abstract][Full Text] [Related]
10. Selective decrease in the rate of cleavage of an intracellular precursor to Rauscher leukemia virus p30 by treatment of infected cells with actinomycin D. Jamjoom GA; Naso RB; Arlinghaus RB J Virol; 1976 Sep; 19(3):1054-72. PubMed ID: 1085824 [TBL] [Abstract][Full Text] [Related]
11. Accumulation and breakdown of RNA-deficient intracellular virus particles in interferon-treated NIH 3T3 cells chronically producing Moloney murine leukemia virus. Aboud M; Hassan Y J Virol; 1983 Feb; 45(2):489-95. PubMed ID: 6187933 [TBL] [Abstract][Full Text] [Related]
15. Effect of interferon on mouse cells chronically infected with murine leukaemia virus: kinetic studies on virus production and virus RNA synthesis. Salzberg S; Bakhanashvili M; Aboud M J Gen Virol; 1978 Jul; 40(1):121-30. PubMed ID: 80442 [TBL] [Abstract][Full Text] [Related]
16. Production of vesicular stomatitis virus with low infectivity by interferon-treated cells. Maheshwari RK; Friedman RM J Gen Virol; 1979 Jul; 44(1):261-4. PubMed ID: 227998 [TBL] [Abstract][Full Text] [Related]
17. Interferon-directed inhibition of chronic murine leukemia virus production in cell cultures: lack of effect on intracellular viral markers. Friedman RM; Chang EH; Ramseur JM; Myers MW J Virol; 1975 Sep; 16(3):569-74. PubMed ID: 51100 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of Rauscher murine leukemia virus growth in vitro by actinomycin D. Bases RE; King AS Virology; 1967 Jun; 32(2):175-83. PubMed ID: 6025874 [No Abstract] [Full Text] [Related]
19. Influence of interferon on the synthesis of virus particles in oncornavirus carrier cell lines. IV. Relevance to the potential application of interferon in natural infectious diseases. Billiau A; Heremans H; Allen PT; De Somer P J Infect Dis; 1976 Jun; 133 Suppl():A51-5. PubMed ID: 180210 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and cleavage processing of oncornavirus proteins during interferon inhibition of virus particle release. Shapiro SZ; Strand M; Billiau A Infect Immun; 1977 Jun; 16(3):742-7. PubMed ID: 70406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]